YES1 and cancer: Proto-oncogene tyrosine-protein kinase (YES1) has been widely reported to stimulate cancer cell growth and migration in various cancer types such as lung cancer (Garmendia et al., 2019), gastric cancer (Mao et al., 2021), and breast cancer (Takeda et al., 2017), which is therefore considered as a novel therapeutic target for cancer therapy (Garmendia et al., 2022).